Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery.

Turan A, You J, Shiba A, Kurz A, Saager L, Sessler DI.

Anesth Analg. 2012 Mar;114(3):552-60. doi: 10.1213/ANE.0b013e318241f6af. Epub 2012 Jan 17.


Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality.

Drenger B, Fontes ML, Miao Y, Mathew JP, Gozal Y, Aronson S, Dietzel C, Mangano DT; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group.

Circulation. 2012 Jul 17;126(3):261-9. doi: 10.1161/CIRCULATIONAHA.111.059527. Epub 2012 Jun 19.


Angiotensin system inhibitors in a general surgical population.

Comfere T, Sprung J, Kumar MM, Draper M, Wilson DP, Williams BA, Danielson DR, Liedl L, Warner DO.

Anesth Analg. 2005 Mar;100(3):636-44, table of contents.


Impact of preoperative angiotensin-converting enzyme inhibitor use on clinical outcomes after cardiac surgery.

Ouzounian M, Buth KJ, Valeeva L, Morton CC, Hassan A, Ali IS.

Ann Thorac Surg. 2012 Feb;93(2):559-64. doi: 10.1016/j.athoracsur.2011.10.058.


Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.

Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1266-73. doi: 10.2215/CJN.05271107. Epub 2008 Jul 30.


The association of preoperative statin use and acute kidney injury after noncardiac surgery.

Argalious MY, Dalton JE, Sreenivasalu T, O'Hara J, Sessler DI.

Anesth Analg. 2013 Oct;117(4):916-23. doi: 10.1213/ANE.0b013e31828175ab. Epub 2013 Jan 25.


Post-perfusion syndrome and disturbed microcirculation after cardiac surgery: the role of angiotensin-converting-enzyme inhibitors.

Boeken U, Feindt P, Mohan E, Zimmermann N, Micek M, Kalweit G, Gams E.

Thorac Cardiovasc Surg. 1999 Dec;47(6):347-51.


Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.

Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R.

J Am Soc Nephrol. 2006 Mar;17(3):889-99. Epub 2006 Feb 15.


No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.

Han SW, Won YW, Yi JH, Kim HJ.

Nephrol Dial Transplant. 2007 Apr;22(4):1150-5. Epub 2007 Jan 25.


Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis.

Shah M, Jain AK, Brunelli SM, Coca SG, Devereaux PJ, James MT, Luo J, Molnar AO, Mrkobrada M, Pannu N, Parikh CR, Paterson M, Shariff S, Wald R, Walsh M, Whitlock R, Wijeysundera DN, Garg AX.

BMC Nephrol. 2014 Apr 2;15:53. doi: 10.1186/1471-2369-15-53.


Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality.

Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD.

J Am Coll Cardiol. 2005 May 17;45(10):1691-9.


Association between intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery.

Glance LG, Dick AW, Mukamel DB, Fleming FJ, Zollo RA, Wissler R, Salloum R, Meredith UW, Osler TM.

Anesthesiology. 2011 Feb;114(2):283-92. doi: 10.1097/ALN.0b013e3182054d06.


The association between nitrous oxide and postoperative mortality and morbidity after noncardiac surgery.

Turan A, Mascha EJ, You J, Kurz A, Shiba A, Saager L, Sessler DI.

Anesth Analg. 2013 May;116(5):1026-33. doi: 10.1213/ANE.0b013e31824590a5. Epub 2012 Jul 19.


Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.

Kheterpal S, Khodaparast O, Shanks A, O'Reilly M, Tremper KK.

J Cardiothorac Vasc Anesth. 2008 Apr;22(2):180-6. doi: 10.1053/j.jvca.2007.12.020.


Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery.

Licker M, Neidhart P, Lustenberger S, Valloton MB, Kalonji T, Fathi M, Morel DR.

Anesthesiology. 1996 Apr;84(4):789-800.


Effects of angiotensin-converting enzyme inhibitor therapy on clinical outcome in patients undergoing coronary artery bypass grafting.

Miceli A, Capoun R, Fino C, Narayan P, Bryan AJ, Angelini GD, Caputo M.

J Am Coll Cardiol. 2009 Nov 3;54(19):1778-84. doi: 10.1016/j.jacc.2009.07.008. Epub 2009 Aug 13.


Renin-angiotensin blockade is associated with increased mortality after vascular surgery.

Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE.

Can J Anaesth. 2010 Aug;57(8):736-44. doi: 10.1007/s12630-010-9330-4. Epub 2010 Jun 4.


Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.

Latini R, Tognoni G, Maggioni AP, Baigent C, Braunwald E, Chen ZM, Collins R, Flather M, Franzosi MG, Kjekshus J, Køber L, Liu LS, Peto R, Pfeffer M, Pizzetti F, Santoro E, Sleight P, Swedberg K, Tavazzi L, Wang W, Yusuf S.

J Am Coll Cardiol. 2000 Jun;35(7):1801-7.

Supplemental Content

Support Center